{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:20:13Z","timestamp":1754486413474},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s40291-023-00658-x","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T02:01:28Z","timestamp":1686276088000},"page":"593-599","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Flow Cytometry of CD5-Positive Hairy Cell Leukemia"],"prefix":"10.1007","volume":"27","author":[{"given":"Diana","family":"Cenariu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioana","family":"Rus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon Thor","family":"Bergthorsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravnit","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai","family":"Cenariu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Greiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian-Bogdan","family":"Tigu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia","family":"Dima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Selicean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobe","family":"Petrushev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihnea","family":"Zdrenghea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Fromm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen-Mariana","family":"Aanei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciprian","family":"Tomuleasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"issue":"2","key":"658_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1309\/QVJD31TEG9UJ18BQ","volume":"120","author":"TM Jasionowski","year":"2003","unstructured":"Jasionowski TM, Hartung L, Greenwood JH, Perkins SL, Bahler DW. Analysis of CD10+ hairy cell leukemia. Am J Clin Pat. 2003;120(2):228\u201335.","journal-title":"Am J Clin Pat"},{"issue":"2","key":"658_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/PAI.0b013e31825d550a","volume":"21","author":"SD Boyd","year":"2013","unstructured":"Boyd SD, Natkunam Y, Allen JR, Warnke RA. Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results. Appl Immunohistochem Mol Morphol. 2013;21(2):116\u201331.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"7","key":"658_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1182\/blood.V13.7.609.609","volume":"13","author":"BA Bouroncle","year":"1958","unstructured":"Bouroncle BA, Wiseman BK, Doan CA. Leukemic reticuloendotheliosis. Blood. 1958;13(7):609\u201330.","journal-title":"Blood"},{"issue":"5","key":"658_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3322\/canjclin.38.5.280","volume":"38","author":"A Isaacs","year":"1988","unstructured":"Isaacs A, Lindenmann J. Virus interference: I. The interferon. CA Cancer J Clin. 1988;38(5):280\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 2","key":"658_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/10428194.2011.565093","volume":"52","author":"CE Dearden","year":"2011","unstructured":"Dearden CE, Else M, Catovsky D. Long-term results for pentostatin and cladribine treatment of hairy cell leukemia. Leuk Lymphoma. 2011;52(Suppl 2):21\u20134.","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"658_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11912-020-00911-0","volume":"22","author":"M Cross","year":"2020","unstructured":"Cross M, Dearden C. Hairy cell leukaemia. Curr Oncol Rep. 2020;22(5):42.","journal-title":"Curr Oncol Rep"},{"issue":"12","key":"658_CR7","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/ajh.25653","volume":"94","author":"E Maitre","year":"2019","unstructured":"Maitre E, Cornet E, Troussard X. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2019;94(12):1413\u201322.","journal-title":"Am J Hematol"},{"issue":"Suppl 2","key":"658_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/10428194.2011.570820","volume":"52","author":"M Stetler-Stevenson","year":"2011","unstructured":"Stetler-Stevenson M, Tembhare PR. Diagnosis of hairy cell leukemia by flow cytometry. Leuk Lymphoma. 2011;52(Suppl 2):11\u20133.","journal-title":"Leuk Lymphoma"},{"issue":"18","key":"658_CR9","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1158\/0008-5472.CAN-15-0893","volume":"75","author":"N Poret","year":"2015","unstructured":"Poret N, Fu Q, Guihard S, et al. CD38 in hairy cell leukemia is a marker of poor prognosis and a new target for therapy. Can Res. 2015;75(18):3902\u201311.","journal-title":"Can Res"},{"issue":"12","key":"658_CR10","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/ajh.24936","volume":"92","author":"X Troussard","year":"2017","unstructured":"Troussard X, Cornet E. Hairy cell leukemia 2018: update on diagnosis, risk-stratification, and treatment. Am J Hematol. 2017;92(12):1382\u201390.","journal-title":"Am J Hematol"},{"key":"658_CR11","unstructured":"Tallman MS. Clinical features and diagnosis of hairy cell leukemia, UpToDate, 2023."},{"key":"658_CR12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/cancers14041050","volume":"14","author":"E Maitre","year":"2022","unstructured":"Maitre E, Cornet E, Sala\u00fcn V, Kerneves P, Ch\u00e8ze S, Repesse Y, Damaj G, Troussard X. Immunophenotypic analysis of hairy cell leukemia (HCL) and hairy cell leukemia-like (HCL-like) disorders. Cancers. 2022;14:1050.","journal-title":"Cancers"},{"key":"658_CR13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1182\/bloodadvances.2021005725","volume":"6","author":"S B\u00f6ttcher","year":"2022","unstructured":"B\u00f6ttcher S, Engelmann R, Grigore G, Fernandez PC, Caetano J, Flores-Montero J, Van der Velden VHJ, Novakova M, Philipp\u00e9 J, Ritgen M. Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study. Blood Adv. 2022;6:976\u201392.","journal-title":"Blood Adv"},{"issue":"14","key":"658_CR14","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1182\/blood-2011-09-379339","volume":"119","author":"L Xi","year":"2012","unstructured":"Xi L, Arons E, Navarro W, Calvo KR, Stetler-Stevenson M, Raffeld M, Kreitman RJ. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood. 2012;119(14):3330\u20132.","journal-title":"Blood"},{"issue":"Supplement 1","key":"658_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1182\/blood-2020-140039","volume":"136","author":"S Javidiparsijani","year":"2020","unstructured":"Javidiparsijani S, Choi YK, Arbini AA. A case of CD5 positive hairy cell leukemia with BRAF V600E mutation and lymph node involvement; unique case report and review of the literature. Blood. 2020;136(Supplement 1):17\u20138.","journal-title":"Blood"},{"issue":"12","key":"658_CR16","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/ajh.26367","volume":"96","author":"M Hallek","year":"2021","unstructured":"Hallek M, Al-Sawaf O. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. Am J Hematol. 2021;96(12):1679\u2013705.","journal-title":"Am J Hematol"},{"key":"658_CR17","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1200\/PO.20.00518","volume":"5","author":"D Soong","year":"2021","unstructured":"Soong D, Kumar P, Jatwani K, Park J, Dogan A, Taylor J. Hairy cell leukemia masquerading as CD5+ lymphoproliferative disease: the importance of BRAF V600E testing in diagnosis and treatment. JCO Prec Oncol. 2021;5:1035\u20139.","journal-title":"JCO Prec Oncol"},{"key":"658_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/cyto.b.21785","volume":"96B","author":"DA Salem","year":"2019","unstructured":"Salem DA, Scott D, McCoy CS, Liewehr DJ, Venzon DJ, Arons E, Kreitman RJ, Stetler-Stevenson M, Yuan CM. Differential expression of CD43, CD81, and CD200 in classic versus variant hairy cell leukemia. Cytom Part B. 2019;96B:275\u201382.","journal-title":"Cytom Part B"},{"issue":"7","key":"658_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1515\/CCLM.2006.146","volume":"44","author":"T Szczepa\u0144ski","year":"2006","unstructured":"Szczepa\u0144ski T, van der Velden VH, van Dongen JJ. Flow-cytometric immunophenotyping of normal and malignant lymphocytes. Clin Chem Lab Med. 2006;44(7):775\u201396.","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"658_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.leukres.2012.11.021","volume":"37","author":"H Shao","year":"2013","unstructured":"Shao H, Calvo KR, Gr\u00f6nborg M, Tembhare PR, Kreitman RJ, Stetler-Stevenson M, Yuan CM. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria. Leuk Res. 2013;37(4):401\u20139.","journal-title":"Leuk Res"},{"issue":"6","key":"658_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/cyto.b.21980","volume":"100","author":"L Vittoria","year":"2021","unstructured":"Vittoria L, Bozzi F, Capone I, Carniti C, Lorenzini D, Gobbo M, Bolli N, Aiello A. A rare biclonal Hairy Cell Leukemia disclosed by an integrated diagnostic approach: a case report. Cytom B Clin Cytom. 2021;100(6):692\u20134.","journal-title":"Cytom B Clin Cytom"},{"issue":"2","key":"658_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/cyto.b.21402","volume":"94","author":"T Mahdi","year":"2018","unstructured":"Mahdi T, Rajab A, Padmore R, Porwit A. Characteristics of lymphoproliferative disorders with more than one aberrant cell population as detected by 10-color flow cytometry. Cytom B Clin Cytom. 2018;94(2):230\u20138.","journal-title":"Cytom B Clin Cytom"},{"issue":"4","key":"658_CR23","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/cancers14041050","volume":"14","author":"E Maitre","year":"2022","unstructured":"Maitre E, Cornet E, Sala\u00fcn V, Kerneves P, Ch\u00e8ze S, Repesse Y, Damaj G, Troussard X. Immunophenotypic analysis of hairy cell leukemia (HCL) and hairy cell leukemia-like (HCL-like) disorders. Cancers (Basel). 2022;14(4):1050.","journal-title":"Cancers (Basel)."},{"issue":"1","key":"658_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ctrv.2010.05.003","volume":"37","author":"T Robak","year":"2011","unstructured":"Robak T. Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment. Cancer Treat Rev. 2011;37(1):3\u201310.","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"658_CR25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1309\/AJCPKUM9J4IXCWEU","volume":"136","author":"G Venkataraman","year":"2011","unstructured":"Venkataraman G, Aguhar C, Kreitman RJ, Yuan CM, Stetler-Stevenson M. Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders. Am J Clin Pathol. 2011;136(4):625\u201330.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"658_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1309\/8QYTYQ1CLQMHQ9CL","volume":"123","author":"MH Cessna","year":"2005","unstructured":"Cessna MH, Hartung L, Tripp S, Perkins SL, Bahler DW. Hairy cell leukemia variant: fact or fiction. Am J Clin Pathol. 2005;123(1):132\u20138.","journal-title":"Am J Clin Pathol"},{"key":"658_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01419-z","author":"A Mendez-Hernandez","year":"2023","unstructured":"Mendez-Hernandez A, Moturi K, Hanson V, Andritsos LA. Hairy cell leukemia: where are we in 2023? Curr Oncol Rep. 2023. https:\/\/doi.org\/10.1007\/s11912-023-01419-z.","journal-title":"Curr Oncol Rep"}],"container-title":["Molecular Diagnosis &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-023-00658-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-023-00658-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-023-00658-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T07:32:12Z","timestamp":1692257532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-023-00658-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["658"],"URL":"https:\/\/doi.org\/10.1007\/s40291-023-00658-x","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"assertion":[{"value":"20 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Diana Cenariu, Mihai Cenariu, Jon Thor Bergthorsson, and Victor Greiff are financed by an international collaborative grant of the European Economic Space between Romania, Iceland, and Norway 2014\u20132021 (Grant no 21-COP-0034).\u00a0Diana Cenariu also received funding from a grant of the National Research Ministry of Romania -\u00a0PN-III-P4-ID-PCE-2020-1118.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Diana Cenariu, Ioana Rus, Jon Thor Bergthorsson, Ravnit Grewal, Mihai Cenariu, Victor Greiff, Bogdan Tigu, Delia Dima, Mihnea Zdrenghea, Cristina Selicean, Bobe Petrushev, Jonathan Fromm, Carmen-Mariana Aanei, and Ciprian Tomuleasa declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Data supporting the results reported in the article can be found at Medfuture Research Center for Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The study was approved by the Ethics committee of the Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed written consent was obtained from the patient included in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Diana Cenariu, Bogdan Tigu, Cristina Selicean, Mihnea Zdrenghea, Bobe Petrushev, and Mihai Cenariu prepared the samples and performed the flow cytometry analysis; Ioana Rus, Delia Dima, and Ciprian Tomuleasa performed clinical examination of the patient, collected the bone marrow sample, and established the final diagnosis and treatment. Jon Thor Bergthorsson, Victor Greiff, Ravnit Grewal, and Jonathan Fromm provided valuable input on bone marrow analysis methodology, evaluated the results and participated in the preparation of the <i>Discussion<\/i> section, Diana Cenariu, Ioana Rus, and Mihai Cenariu drafted the manuscript; Carmen-Mariana Aanei and Ciprian Tomuleasa reviewed the whole manuscript and established its final form.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}